|
TaKaRa
qpcr kit Qpcr Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primescript+rt-qpcr+kit/pm42114789-163-14-17?v=TaKaRa Average 99 stars, based on 1 article reviews
qpcr kit - by Bioz Stars,
2026-08
99/100 stars
|
Buy from Supplier |
|
TaKaRa
primescripttm rt qpcr kit Primescripttm Rt Qpcr Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primescript+rt-qpcr+kit/pm42092926-370-11-14?v=TaKaRa Average 99 stars, based on 1 article reviews
primescripttm rt qpcr kit - by Bioz Stars,
2026-08
99/100 stars
|
Buy from Supplier |
|
TaKaRa
one step primescript iii rt qpcr mix One Step Primescript Iii Rt Qpcr Mix, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primescript+rt-qpcr+kit/pm42087199-347-20-37?v=TaKaRa Average 96 stars, based on 1 article reviews
one step primescript iii rt qpcr mix - by Bioz Stars,
2026-08
96/100 stars
|
Buy from Supplier |
|
TaKaRa
pcr qpcr Pcr Qpcr, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primescript+rt-qpcr+kit/pm42082827-418-11-19?v=TaKaRa Average 99 stars, based on 1 article reviews
pcr qpcr - by Bioz Stars,
2026-08
99/100 stars
|
Buy from Supplier |
|
Vazyme Biotech Co
primescript rt reagent kit Primescript Rt Reagent Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primescript+rt-qpcr+kit/pm42029805-88-18-23?v=Vazyme+Biotech+Co Average 97 stars, based on 1 article reviews
primescript rt reagent kit - by Bioz Stars,
2026-08
97/100 stars
|
Buy from Supplier |
|
TaKaRa
qpcr mix Qpcr Mix, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primescript+rt-qpcr+kit/pm41965457-132-4-7?v=TaKaRa Average 99 stars, based on 1 article reviews
qpcr mix - by Bioz Stars,
2026-08
99/100 stars
|
Buy from Supplier |
|
TaKaRa
revertra ace qpcr rt kit ![]() Revertra Ace Qpcr Rt Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primescript+rt-qpcr+kit/pmc13001056-67-9-15?v=TaKaRa Average 99 stars, based on 1 article reviews
revertra ace qpcr rt kit - by Bioz Stars,
2026-08
99/100 stars
|
Buy from Supplier |
|
TaKaRa
one step tb green primescript rt qpcr kit ii ![]() One Step Tb Green Primescript Rt Qpcr Kit Ii, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primescript+rt-qpcr+kit/pmc13057319-66-8-15?v=TaKaRa Average 96 stars, based on 1 article reviews
one step tb green primescript rt qpcr kit ii - by Bioz Stars,
2026-08
96/100 stars
|
Buy from Supplier |
Journal: Journal of Advanced Research
Article Title: Direct pharmacological targeting of Piezo1 by Paeoniflorin: a novel therapeutic approach for renal fibrosis
doi: 10.1016/j.jare.2025.07.015
Figure Lengend Snippet: PF effectively improves endothelial function (A) Hypoxia (1 % O 2 )-impaired HUVEC proliferation (CCK-8 assay) was rescued by PF (400 μM) at 48 h (n = 6). (B-D) Matrigel tube formation assay. (B) Representative images showing PF restored capillary-like structures under hypoxia. (C) Branching points and (D) total tube length quantified (n = 3). Scale bar: 100 μm. (E–K) PF modulated endothelial regulators in renal tissues. (E-G) eNOS, ANG-II and ET-1 mRNA by RT-qPCR. (H) Representative immunoblots and (I-K) quantification of eNOS, ANG-II and ET-1 protein (n = 5–6). (L–M) Serum levels of nitric oxide (NO, L) (n = 4) and ANG-II (M) (n = 6) detected by ELISA. Data presented as mean ± SEM. *p < 0.05, ** p < 0.01, *** p < 0.001 vs. CTL/Hypoxia; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. CRF/ Hypoxia + PF.
Article Snippet: The RNA was then reverse-transcribed into cDNA using the
Techniques: CCK-8 Assay, Tube Formation Assay, Quantitative RT-PCR, Western Blot, Enzyme-linked Immunosorbent Assay
Journal: Journal of Advanced Research
Article Title: Direct pharmacological targeting of Piezo1 by Paeoniflorin: a novel therapeutic approach for renal fibrosis
doi: 10.1016/j.jare.2025.07.015
Figure Lengend Snippet: PF attenuates Yoda1-induced Ca 2+ influx via functional modulation of Piezo1 channels (A) Immunofluorescence co-localization of Piezo1 (green) and PECAM-1 (red) in glomerular endothelium. Nuclei: DAPI (blue). Scale bar: 20 μm. (B-D) Renal Piezo1 expression analysis. (B) Piezo1 mRNA levels by RT-qPCR. (C) Representative Western blot bands. (D) Quantitative protein analysis normalized to GAPDH. (n = 5–6) (E–F) Intracellular Ca 2+ flux in HUVECs. Fluo-3 AM (5 μM)-labeled cells pre-treated with PF (400 μM, 1 h) or vehicle, then stimulated with Yoda1 (5 μM). PF significantly attenuated Yoda1-induced Ca2 + influx. Images captured via confocal microscopy (λex/λem: 488/530 nm). Scale bar: 20 μm. (G–H) Quantification of baseline (K) and Peak relative value (L) (n = 6). (I-J) Molecular docking of PF to Piezo1. (I) 3D structure showing hydrogen bonds (yellow dashes) with CYS977/PHE984/LYS988/LYS1154 and ARG1295. (J) 2D interaction map highlighting hydrophobic contacts and polar interactions. (K-L) Surface plasmon resonance (SPR) analysis. (K) Binding kinetics showing KD = 2.44 μM. (L) Sensorgrams of concentration-dependent binding.(M−Q) EndMT marker expression in HUVECs. (M) Western blot analysis of (N) eNOS, (O) VE-cadherin, (P) Vimentin, and (Q) TGF-β1. Quantification normalized to GAPDH (n = 3). Data presented as mean ± SEM. *p < 0.05, ** p < 0.01, *** p < 0.001 vs. CTL/Yoda1; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. CRF. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Article Snippet: The RNA was then reverse-transcribed into cDNA using the
Techniques: Functional Assay, Immunofluorescence, Expressing, Quantitative RT-PCR, Western Blot, Labeling, Confocal Microscopy, SPR Assay, Binding Assay, Concentration Assay, Marker
Journal: Journal of Advanced Research
Article Title: Direct pharmacological targeting of Piezo1 by Paeoniflorin: a novel therapeutic approach for renal fibrosis
doi: 10.1016/j.jare.2025.07.015
Figure Lengend Snippet: PF inhibits matrix stiffness-induced acceleration of EndMT through Piezo1 activation (A–F) Matrix stiffness-dependent protein modulation in HUVECs. HUVECs were cultured on polyacrylamide hydrogels with soft (1.00 ± 0.31 kPa) or stiff (40.40 ± 2.39 kPa) for 48 h, with or without PF. (A) Western blot analysis of (B) Piezo1, (C) VE-Cadherin, (D) eNOS, (E) Vimentin, and (F) TGF-β1. Quantification normalized to GAPDH. (n = 3; *p < 0.05, **p < 0.01 vs. soft; #p < 0.05 vs. stiff without PF). (G-L) Piezo1 knockdown reverses stiffness-induced EndMT. HUVECs transfected with Piezo1 siRNA (50 nM, 24 h) or scramble siRNA (control) were cultured on stiffness hydrogels (40.40 ± 2.39 kPa) ± PF (400 μM). (G) Western blot analysis of (H) Piezo1, (I) VE-Cadherin, (J) eNOS, (K) Vimentin, and (L) TGF-β1. Quantification normalized to GAPDH (n = 3; *p < 0.05, **p < 0.01 vs. scramble siRNA control; ns vs. Piezo1 siRNA without PF).(M) Schematic of co-culture model. HUVECs and NRK-49F fibroblasts were co-cultured on stiffness-tunable hydrogels using a transwell system (0.4 μm pore size) for 5 days to assess paracrine signaling. (N) TGF-β1 levels in HUVEC supernatants from the co-culture system were quantified by ELISA. (n = 3; *p < 0.05 vs. softness; #p < 0.05 vs. stiffness without PF). (O) Fibrotic gene expression in NRK-49F cells. RT-qPCR analysis of Fibronectin , COL1A1 , Vimentin , and TGF-β1 mRNA levels. Data normalized to 18 s ( n = 3). (P-S) Fibrotic protein expression in NRK-49F cells. (P) Western blot analysis of (Q) Fibronectin, (R) COL1, (S) Vimentin, and (T) TGF-β1. Quantification normalized to GAPDH (n = 3). (U–V) Immunofluorescence of Fibronectin (red) in NRK-49F cells. Nuclei stained with DAPI (blue). (U) Representative images. (V) Quantification of fluorescence intensity using ImageJ (n = 3). Scale bar: 20 μm. Data presented as mean ± SEM. *p < 0.05, **p < 0.01 vs . softness co-culture; # p < 0.05 vs . stiffness co-culture without PF . (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Article Snippet: The RNA was then reverse-transcribed into cDNA using the
Techniques: Activation Assay, Cell Culture, Western Blot, Knockdown, Transfection, Control, Co-Culture Assay, Pore Size, Enzyme-linked Immunosorbent Assay, Gene Expression, Quantitative RT-PCR, Expressing, Immunofluorescence, Staining, Fluorescence
Journal: Journal of Advanced Research
Article Title: Direct pharmacological targeting of Piezo1 by Paeoniflorin: a novel therapeutic approach for renal fibrosis
doi: 10.1016/j.jare.2025.07.015
Figure Lengend Snippet: PF inhibits EndMT through the Piezo1-mediated HIF-1α signaling pathway (A–C) Renal HIF-1α expression analysis. (A) Representative RT-qPCR analysis of HIF-1α mRNA levels in kidney tissues. Data normalized to 18 s . (B-C) Western blot and quantification of HIF-1α protein expression in renal tissues. Data normalized to GAPDH (n = 5–6) . (D–H) Effects of PF or HIF-1α inhibitor BAY 87-2243 (10 μM, 24 h) on endothelial markers in HUVECs cultured with or without Piezo1 activation by Yoda1 (5 μM, 12 h). (D) Western blot analysis of (E) Piezo1, (F) HIF-1α, (G) VE-Cadherin, and (H) eNOS. Quantification normalized to GAPDH. Quantification showing Yoda1-induced Piezo1 upregulation and HIF-1α/VE-Cadherin/eNOS downregulation, reversed by PF or BAY 87-2243 (n = 3). (I-K) PF or BAY 87-2243 inhibits Yoda1-induced EndMT in HUVECs. (I) Western blot analysis of (J) Vimentin and (K) TGF-β1. Yoda1 increased Vimentin and TGF-β1, suppressed by PF or BAY 87-2243 (n = 3). (L) Schematic of HUVEC-NRK-49F co-culture. HUVECs pre-treated with/without Yoda1 (5 μM, 6 h) were co-cultured with NRK-49F fibroblasts for 48 h. (M) TGF-β1 levels in HUVEC supernatants from the co-culture system were quantified by ELISA. (N) RT-qPCR analysis of Fn1 , COL1A1 , and Vimentin mRNA in NRK-49F cells co-cultured with Yoda1-treated HUVECs. PF attenuated Yoda1-induced fibrotic marker expression (n = 3). (O-S) Western blot validation of (P) Fibronectin, (Q) COL1, (R) Vimentin, and (S) TGF-β1 in NRK-49F cells. PF reduced Yoda1-induced protein expression (n = 3). Data presented as mean ± SEM. *p < 0.05, ** p < 0.01, *** p < 0.001 vs. CTL/control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. CRF/Yoda1.
Article Snippet: The RNA was then reverse-transcribed into cDNA using the
Techniques: Expressing, Quantitative RT-PCR, Western Blot, Cell Culture, Activation Assay, Co-Culture Assay, Enzyme-linked Immunosorbent Assay, Marker, Biomarker Discovery, Control
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Host-directed microRNA-based intervention against intracellular Staphylococcus aureus : high-throughput screening identifies miR-4430, miR-147a, and miR-1249-5p as multifunctional antimicrobial candidates
doi: 10.3389/fcimb.2026.1772100
Figure Lengend Snippet: Validation of RNA-seq results by RT-qPCR in A549 cells transfected with miR-4430, miR-147a, or miR-1249-5p and infected with S. aureus USA300. (A) The Expression of STARD4 was significantly upregulated in cells treated with miR-147a and miR-1249-5p. (B) Expression of ITGA5 was significantly downregulated following treatment with miR-147a and miR-1249-5p. (C–E) Expression of PARP12 , STAT1 , and INSIG1 was significantly upregulated in cells treated with miR-4430. These results confirm the RNA-seq findings, supporting the downstream transcriptional effects of miR-4430 on immune signalling, whereas miR-147a and miR-1249-5p are associated with downstream modulation of adhesion- and lipid-related genes that influence S. aureus internalisation. Data represent three independent biological replicates (n = 3). * p < 0.05; ** p < 0.01; *** p < 0.001.
Article Snippet: Reverse transcription qPCR (RT-qPCR) was performed using the
Techniques: Biomarker Discovery, RNA Sequencing, Quantitative RT-PCR, Transfection, Infection, Expressing